Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma
1. 37% of study patients had an objective response to treatment with atezolizumab. 2. Median progression-free survival was 20.8 months....
1. 37% of study patients had an objective response to treatment with atezolizumab. 2. Median progression-free survival was 20.8 months....
1. 5-year recurrence incidence was 2.5% at follow-up. 2. Overall survival at 5 years without radiotherapy was 97.2%, with a...
1. At 24 months, more participants in the pembrolizumab group were alive without an event, compared with the placebo group....
1. Initiating colorectal cancer screening at age 45 results in 12,188 fewer cases and 5,261 fewer deaths over a 40...
1. Five-year disease-free survival was greater in patients who had ≤10% viable tumour or brisk tumour-infiltrating lymphocytes 2. Overall survival...
1. Baseline mGPS measures reliably predict the prognostic outcome of treatment in patients with metastatic renal cell carcinoma (mRCC) 2....
1 .Progression-free survival is improved in patients receiving fulvestrant-capivasertib therapy as compared to fulvestrant-placebo treatment. 2. Overall survival at 18...
1. The 3-year incidence of breast cancer in the study group was 8.9% compared to 9.2% in the control group...
1. A significantly slower rate of breast density decline over time was observed in the breast that developed cancer when...
1. Pain response at 3 months post-treatment show no advantage of stereotactic radiosurgery vs. conventional external beam radiotherapy 2. Adverse...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.